Found 249 results[ Author] Title Type Year
Filters: First Letter Of Last Name is C [Clear All Filters]
Tacrolimus/Sirolimus vs Tacrolimus/Methotrexate as GVHD Prophylaxis After Matched, Related Donor Allogeneic HCT. Blood, 124, 1372-1377. presented at the 08/2014. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24982504. (2014).
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT. Blood, 124(8), 1372-7. presented at the 2014 Aug 21. doi:10.1182/blood-2014-04-567164. (2014).
Sirolimus Is Associated With Veno-Occlusive Disease of the Liver After Myeloablative Allogeneic Stem Cell Transplantation. Blood, 112, 4425-4431. presented at the 12/2008. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/18776081. (2008).
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantation. Blood, 112(12), 4425-31. presented at the 2008 Dec 01. doi:10.1182/blood-2008-07-169342. (2008).
Tacrolimus/Sirolimus vs. Tacrolimus/Methotrexate for GVHD Prophylaxis After HLA-Matched, Related Donor Hematopoietic Stem Cell Transplantation: Results of BMT CTN Trial 0402. In 54th Annual ASH Meeting. presented at the 08/12/2012, Atlanta, GA. Retrieved from http://www.hematology.org/Meetings/Annual-Meeting/. (2012).
Intravitreal Anti-VEGF Therapy for Advanced Ocular Disease of Von Hippel-Lindau Disease. presented at the 2004.. (2004).
The Relationship of Omega(n)-3 Long-Chain Polyunsaturated Fatty Acid (LCPUFA) Intake and Regular Aspirin (ASA) Use with Prevalent Neovascular Age-Related Macular Degeneration. In Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO). presented at the 01/05/2005, Fort Lauderdale, FL. Retrieved from http://www.arvo.org/Conferences_and_Courses/Past_Conferences/. (2005).
Associations of Mortality and Diabetes Complications in Patients with Type 1 and Type 2 Diabetes: Early Treatment Diabetic Retinopathy Study Report No. 27. Diabetes Care, 28, 617-625. presented at the 03/2005. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15735198. (2005).
Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes: early treatment diabetic retinopathy study report no. 27. Diabetes Care, 28(3), 617-25. presented at the 2005 Mar. doi:10.2337/diacare.28.3.617. (2005).
Practice Based Research Networks Impacting Periodontal Care: PEARL Initiative. J Periodontol, 84, 567-571. presented at the 05/2013. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22702516. (2013).
The PBRN initiative: transforming new technologies to improve patient care. J Dent Res, 91(7 Suppl), 12S-20S. presented at the 2012 Jul. doi:10.1177/0022034512447948. (2012).
The role of interim analysis as a quality assurance function in practice-based research network clinical studies. Compend Contin Educ Dent, 30(6), 352-4. presented at the 2009 Jul-Aug.. (2009).
An Assessment of the Perceived Benefits and Challenges of Participating in a Practice-based Research Network. Prim Dent J, 1, 50-57. presented at the 10/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23720922. (2012).
The Role of Practice Based Research Networks (PBRN) in the Spectrum of Clinical Trials. In . presented at the 05/2007.. (2007).
GCP Compliance Supporting Efficacy/Effectiveness Studies. In . presented at the 22/06/2011, Bethesda, MD. Retrieved from http://pbrn.ahrq.gov/portal/server.pt?open=512&objID=854&PageID=11984&mode=2&cached=true#archives. (2011).
An assessment of the perceived benefits and challenges of participating in a practice-based research network. Prim Dent J, 1(1), 50-7. presented at the 2012 Oct. doi:10.1308/205016812803838393. (2012).
Advantages of the Dental Practice-Based Research Network Initiative and its Role in Dental Education. J Dent Educ, 75, 1053-1060. presented at the 08/2011. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21828299. (2011).
Advantages of the dental practice-based research network initiative and its role in dental education. J Dent Educ, 75(8), 1053-60. presented at the 2011 Aug.. (2011).
The Role of Interim Analysis as a Quality Assurance Function in Practice-Based Research Network Clinical Studies. Compend Contin Educ Dent, 30, 352-354. presented at the 07-08/2009. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19715012. (2009).
Practice-Based Research Network Infrastructure Design for Institutional Review Board Risk Assessment and Generalizability of Clinical Results. Therapeutic Innovation & Regulatory Science, 47, 82-89. presented at the 01/2013. Retrieved from http://dij.sagepub.com/content/47/1/82. (2013).
Identifying Investigators to Conduct Randomized Controlled Trials (RCTs) in a Practice Based Research Network (PBRN). In Inventory and Evaluation of Clinical Research Networks. presented at the 05/2007.. (2007).
The PBRN Initiative: Transforming New Technologies to Improve Patient Care. J Dent Res, 91, S12-S20. presented at the 07/2012. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22699662. (2012).
Practice based research networks impacting periodontal care: PEARL Initiative. J Periodontol, 84(5), 567-71. presented at the 2013 May. doi:10.1902/jop.2012.120116. (2013).
Chapter 14.4: Recruitment and Retention Strategies for Practice-Based Research Network Investigators. In Clinical Research in Oral Health. presented at the 2010, Hoboken, NJ: Wiley - Blackwell.. (2010).
Person-centric clinical trials: defining the N-of-1 clinical trial utilizing a practice-based translational network. Clin Investig (Lond), 5(2), 145-159. presented at the 2015. doi:10.4155/cli.14.126. (2015).